These acylcarnitines are biomarkers in the diagnosis of metabolic disorders such as carnitine palmitoyltransferase deficiency type I, type II, carnitine-acylcarnitine translocase (CACT) deficiency, Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, glutaric acidemia type II
[DOI] [PubMed] [PMC] Katsyuba E, Auwerx J
The supplier company is located in Shanghai, Shanghai, and is one of the leading sellers of listed products
Lili Ladaga Editor GLP-1 RA Prescription Trends: January 2018 March 2025
Also, since depressive outcomes were assessed with different rating scales, we grouped them based on the scales most frequently used and performed a secondary meta-analysis within the HDRS (n=9), BDI (n=4), and MADRS (n=3) groups